ANALYST RECOMMENDATIONS : Barclays, Eli Lilly, Meta Platforms, NatWest, Reckitt...

Every morning, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.

• Barclays: Morgan Stanley maintains in-line recommendation with a price target reduced from 210 to 190 GBp.
• Eagle Materials: J.P. Morgan downgrades to underweight from neutral. PT up 3.2% to $190.
• Eli Lilly: CICC initiated coverage with a recommendation of market perform. PT up 1.8% to $474.31.
• HubSpot: Piper Sandler downgrades to neutral from overweight. PT down 0.2% to $520.
• Martin Marietta: J.P. Morgan downgrades to neutral from overweight. PT up 4.6% to $470.
• Meta Platforms: KeyBanc Capital Markets raises price target to $335 from $280. Maintains overweight rating.
• Mondi: J.P. Morgan upgrades from neutral to overweight, targeting GBp 1355.
• NatWest: Morgan Stanley remains Overweight with a price target reduced from 350 to 320 GBp.
• Neurocrine Bio: BMO Capital Markets upgrades to market perform from underperform. PT up 1.5% to $96.
• Ocado: Morgan Stanley remains Underweight with a price target reduced from 430 to 390 GBp.
• Reckitt: HSBC remains Buy with a price target reduced from 7900 to 7600 GBp.
• Smurfit Kappa: Morgan Stanley maintains in-line recommendation with a price target reduced from 3500 to 3200 GBp.
• Textron: Citi reinstated coverage with a recommendation of buy. PT set to $90 - a 34% increase from last price.
• TransDigm: Citi initiated coverage with a recommendation of buy. PT set to $1,042.